Send to friend Linked
Cerus
|
| Website | http://www.cerus.com/ |
|---|---|
| Location | San Francisco |
| Industry | Healthcare & Pharmaceuticals |
| Revenue | unknown |
| Investment | unknown |
| Growth | unknown |
| Employees | unknown |
“Cerus Corporation is a biopharmaceutical company focused on the development and commercialization of the INTERCEPT Blood System. The INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. The company currently markets the INTERCEPT system for both platelets and plasma in Europe and, through distributors and licensees, in countries around the world that recognize the CE mark. The company is also in Phase I clinical trials for development of the INTERCEPT system for red blood cells in the United States.”
(Source: Cerus)
-
News: Cerus initiates Phase I study for Intercept red blood cell system
-
News: Cerus Initiates Phase I Clinical Trial for INTERCEPT Red Blood Cell System
-
News: Celebrate Christmas "Fast" With Lamborghini Gear
-
News: Zacks #1 Rank Additions for Friday
-
News: Lamborghini releases new accesorries for a perfect Christmas
-
News: What to buy the Lamborghini Fan this Christmas
-
News: Celebrate Christmas at over 200 mph, Lamborghini style
-
News: Zacks #1 Rank Additions for Monday
-
News: Cerus Corporation Announces Third Quarter Financial Results
-
News: Bacterial Risks Prompt German Safety Measures